We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PROV:NASDAQProvident Financial Holdings, Inc. Analysis

Data as of 2026-06-07 - not real-time

$16.92

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Provident Financial (PROV) is trading at $16.92, just above its 200‑day moving average and slightly below the 50‑day average, with the 20‑day SMA still higher, indicating short‑term pressure. The RSI sits near 44, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, pointing to a modest downside bias. The stock is priced at a trailing PE of about 18, a shade above the regional‑bank industry average of 17, but its forward PE drops to roughly 13 and the price‑to‑book ratio is under 1 (0.85), hinting at potential undervaluation. Dividend yield of 3.3% and a 60% payout ratio add income appeal, especially with the ex‑dividend date on May 14.
Fundamentally, revenue has contracted by ~11% YoY, yet operating and profit margins remain healthy (≈22% and 15%). Cash on hand (~$57 M) comfortably exceeds operating cash flow, though total debt (~$187 M) is sizable. The company’s beta (~0.22) and 30‑day volatility (~6.7%) are low, supporting a defensive profile, while the Fear & Greed Index at 83 signals strong market optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price near resistance
  • Neutral RSI indicating limited upside
  • Attractive dividend yield supporting demand

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE discount to industry average
  • Price‑to‑book below 1 suggesting value cushion
  • Sustainable dividend with reasonable payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low beta and volatility for defensive positioning
  • Stable dividend income stream
  • Revenue decline and sector headwinds temper growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-11.20%
Profit Margin15.39%
P/E Ratio18.2
ROE4.77%
ROA0.49%
P/B Ratio0.8
Op. Cash Flow$8.1M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI44.1
Support$16.44
Resistance$17.39
MA 20$17.04
MA 50$16.93
MA 200$16.08
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Target Price$16.50
Upside/Downside-2.48%
GradeUndervalued
TypeBlend
Dividend Yield3.30%

Risk Assessment

Beta0.22
Volatility6.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.